FHIR IG analytics| Package | lt.hl7.fhir.prostate |
| Resource Type | QuestionnaireResponse |
| Id | QuestionnaireResponse-questionnaireresponse-prostate-pathology-espbi-example.json |
| FHIR Version | R5 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
English
Generated Narrative: QuestionnaireResponse questionnaireresponse-prostate-pathology-espbi-example
Language: en
| LinkID | Text | Definition | Answer |
|---|---|---|---|
  questionnaireresponse-prostate-pathology-espbi-example | Questionnaire:Prostate pathology structured report | ||
  grp-specimen | |||
  bioptate-length-mm | 22 mm (Details: UCUM codemm = 'mm') | ||
 specimen-quality | Prostate questionnaire answer options (illustrative): specimen-satisfactory (Specimen satisfactory for evaluation) | ||
| grp-treatment-effect | |||
| treatment-effect | Prostate questionnaire answer options (illustrative): treatment-unknown (Treatment effect unknown) | ||
| grp-histology | |||
| histological-type | Prostate questionnaire answer options (illustrative): hist-acinar (Acinar adenocarcinoma (conventional)) | ||
| histological-comment | Acinar pattern; correlate with MRI. | ||
| grp-grade | |||
| isup-grade-group | Prostate questionnaire answer options (illustrative): isup-gg1 (ISUP Grade Group 1 (Gleason 3+3)) | ||
| grp-idc-cribriform | |||
| idc-status | Prostate questionnaire answer options (illustrative): idc-absent (Intraductal carcinoma not identified) | ||
| cribriform-status | Prostate questionnaire answer options (illustrative): cribriform-na (Cribriform not applicable) | ||
| grp-additional-grade-burden | |||
| pattern4-pct-band | Prostate questionnaire answer options (illustrative): pattern4-pct-lte5 (Pattern 4 %: ≤5%) | ||
| tumor-percent-in-biopsy | Prostate questionnaire answer options (illustrative): tumor-pct-1-5 (Tumour % in biopsy: 1–5%) | ||
| grp-invasion | |||
 periprostatic-fat-invasion | Prostate questionnaire answer options (illustrative): periprostatic-absent (Periprostatic fat invasion: not identified) | ||
| perineural-invasion | Prostate questionnaire answer options (illustrative): perineural-absent (Perineural invasion not identified) | ||
| lymphovascular-invasion | Prostate questionnaire answer options (illustrative): lymphovascular-absent (Lymphovascular invasion unidentifiable / not available) | ||
| Documentation for this format | |||
Lithuanian
Generated Narrative: QuestionnaireResponse questionnaireresponse-prostate-pathology-espbi-example
Language: en
| LinkID | Text | Definition | Answer |
|---|---|---|---|
| questionnaireresponse-prostate-pathology-espbi-example | Questionnaire:Prostate pathology structured report | ||
| grp-specimen | |||
| bioptate-length-mm | 22 mm (Details: UCUM codemm = 'mm') | ||
| specimen-quality | Prostate questionnaire answer options (illustrative): specimen-satisfactory (Specimen satisfactory for evaluation) | ||
| grp-treatment-effect | |||
| treatment-effect | Prostate questionnaire answer options (illustrative): treatment-unknown (Treatment effect unknown) | ||
| grp-histology | |||
| histological-type | Prostate questionnaire answer options (illustrative): hist-acinar (Acinar adenocarcinoma (conventional)) | ||
| histological-comment | Acinar pattern; correlate with MRI. | ||
| grp-grade | |||
| isup-grade-group | Prostate questionnaire answer options (illustrative): isup-gg1 (ISUP Grade Group 1 (Gleason 3+3)) | ||
| grp-idc-cribriform | |||
| idc-status | Prostate questionnaire answer options (illustrative): idc-absent (Intraductal carcinoma not identified) | ||
| cribriform-status | Prostate questionnaire answer options (illustrative): cribriform-na (Cribriform not applicable) | ||
| grp-additional-grade-burden | |||
| pattern4-pct-band | Prostate questionnaire answer options (illustrative): pattern4-pct-lte5 (Pattern 4 %: ≤5%) | ||
| tumor-percent-in-biopsy | Prostate questionnaire answer options (illustrative): tumor-pct-1-5 (Tumour % in biopsy: 1–5%) | ||
| grp-invasion | |||
| periprostatic-fat-invasion | Prostate questionnaire answer options (illustrative): periprostatic-absent (Periprostatic fat invasion: not identified) | ||
| perineural-invasion | Prostate questionnaire answer options (illustrative): perineural-absent (Perineural invasion not identified) | ||
| lymphovascular-invasion | Prostate questionnaire answer options (illustrative): lymphovascular-absent (Lymphovascular invasion unidentifiable / not available) | ||
| Documentation for this format | |||
FHIR
FHIRsmith{
"resourceType": "QuestionnaireResponse",
"id": "questionnaireresponse-prostate-pathology-espbi-example",
"language": "en",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"questionnaire": "https://hl7.lt/fhir/prostate/Questionnaire/prostate-pathology-espbi",
"status": "completed",
"subject": {
"reference": "Patient/patient-male-example"
},
"authored": "2024-05-28T14:00:00Z",
"item": [
{
"linkId": "grp-specimen",
"item": [
{
"linkId": "bioptate-length-mm",
"answer": [
{
"valueQuantity": {
"value": 22,
"unit": "mm",
"system": "http://unitsofmeasure.org",
"code": "mm"
}
}
]
},
{
"linkId": "specimen-quality",
"answer": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "specimen-satisfactory",
"display": "Specimen satisfactory for evaluation"
}
}
]
}
]
},
{
"linkId": "grp-treatment-effect",
"item": [
{
"linkId": "treatment-effect",
"answer": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "treatment-unknown",
"display": "Treatment effect unknown"
}
}
]
}
]
},
{
"linkId": "grp-histology",
"item": [
{
"linkId": "histological-type",
"answer": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "hist-acinar",
"display": "Acinar adenocarcinoma (conventional)"
}
}
]
},
{
"linkId": "histological-comment",
"answer": [
{
"valueString": "Acinar pattern; correlate with MRI."
}
]
}
]
},
{
"linkId": "grp-grade",
"item": [
{
"linkId": "isup-grade-group",
"answer": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "isup-gg1",
"display": "ISUP Grade Group 1 (Gleason 3+3)"
}
}
]
}
]
},
{
"linkId": "grp-idc-cribriform",
"item": [
{
"linkId": "idc-status",
"answer": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "idc-absent",
"display": "Intraductal carcinoma not identified"
}
}
]
},
{
"linkId": "cribriform-status",
"answer": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "cribriform-na",
"display": "Cribriform not applicable"
}
}
]
}
]
},
{
"linkId": "grp-additional-grade-burden",
"item": [
{
"linkId": "pattern4-pct-band",
"answer": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "pattern4-pct-lte5",
"display": "Pattern 4 %: ≤5%"
}
}
]
},
{
"linkId": "tumor-percent-in-biopsy",
"answer": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "tumor-pct-1-5",
"display": "Tumour % in biopsy: 1–5%"
}
}
]
}
]
},
{
"linkId": "grp-invasion",
"item": [
{
"linkId": "periprostatic-fat-invasion",
"answer": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "periprostatic-absent",
"display": "Periprostatic fat invasion: not identified"
}
}
]
},
{
"linkId": "perineural-invasion",
"answer": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "perineural-absent",
"display": "Perineural invasion not identified"
}
}
]
},
{
"linkId": "lymphovascular-invasion",
"answer": [
{
"valueCoding": {
"system": "https://tx.hl7.lt/fhir/CodeSystem/prostate-questionnaire-options",
"code": "lymphovascular-absent",
"display": "Lymphovascular invasion unidentifiable / not available"
}
}
]
}
]
}
]
}